(Q44405600)

2 December 2017

Characteristics and time course of severe glimepiride- versus glibenclamide-induced hypoglycaemia (English)

1 reference

2 December 2017

1 reference

1 reference

https://api.crossref.org/works/10.1007/S00228-003-0592-4

24 December 2023

author name string

E-H Egberts

4

1 reference

2 December 2017

A. Holstein

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12698302

24 December 2023

A. Plaschke

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12698302

24 December 2023

C. Hammer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12698302

24 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12698302

24 December 2023

publication date

16 April 2003

1 reference

full work available at URL

2 December 2017

http://link.springer.com/content/pdf/10.1007/s00228-003-0592-4.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/S00228-003-0592-4

http://link.springer.com/article/10.1007/s00228-003-0592-4/fulltext.html

24 December 2023

1 reference

https://api.crossref.org/works/10.1007/S00228-003-0592-4

http://link.springer.com/content/pdf/10.1007/s00228-003-0592-4

24 December 2023

1 reference

https://api.crossref.org/works/10.1007/S00228-003-0592-4

European Journal of Clinical Pharmacology

24 December 2023

published in

1 reference

2 December 2017

59

1 reference

2 December 2017

2

1 reference

2 December 2017

91-97

1 reference

https://scigraph.springernature.com/pub.10.1007/s00228-003-0592-4

2 December 2017

0 references

cites work

Lower incidence of severe hypoglycaemia in patients with type 2 diabetes treated with glimepiride versus glibenclamide

1 reference

https://api.crossref.org/works/10.1007%2FS00228-003-0592-4

Higher incidence of severe hypoglycaemia leading to hospital admission in Type 2 diabetic patients treated with long-acting versus short-acting sulphonylureas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-003-0592-4

Behaviour of glibenclamide on repeated administration to diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-003-0592-4

Hypoglycemic activity of glyburide (glibenclamide) metabolites in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-003-0592-4

Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. I. Binding characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-003-0592-4

Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at beta-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-003-0592-4

Prediction of creatinine clearance from serum creatinine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-003-0592-4

Glimepiride block of cloned beta-cell, cardiac and smooth muscle K(ATP) channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-003-0592-4

Long-term treatment of type 2 diabetic patients with the new oral antidiabetic agent glimepiride (Amaryl): a double-blind comparison with glibenclamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-003-0592-4

Clinical evaluation of glimepiride versus glyburide in NIDDM in a double-blind comparative study. Glimepiride/Glyburide Research Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-003-0592-4

Comparative effects of glimepiride and glibenclamide on blood glucose, C-peptide and insulin concentrations in the fasting and postprandial state in normal man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-003-0592-4

Extrapancreatic effects of sulfonylureas--a comparison between glimepiride and conventional sulfonylureas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-003-0592-4

Effect of glimepiride on insulin-stimulated glycogen synthesis in cultured human skeletal muscle cells: a comparison to glibenclamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-003-0592-4

Pharmacokinetics and safety of glimepiride at clinically effective doses in diabetic patients with renal impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-003-0592-4

Pharmacokinetics and pharmacodynamics of the hydroxymetabolite of glimepiride (Amaryl) after intravenous administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-003-0592-4

Comparative tolerability profiles of oral antidiabetic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-003-0592-4

Impact of CYP2C9 amino acid polymorphisms on glyburide kinetics and on the insulin and glucose response in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-003-0592-4

Effects of fluconazole and fluvoxamine on the pharmacokinetics and pharmacodynamics of glimepiride

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-003-0592-4

Effect of gemfibrozil on the pharmacokinetics and pharmacodynamics of glimepiride

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-003-0592-4

Sulphonylurea dose-response relationships: relation to clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-003-0592-4

Prolonged sulfonylurea-induced hypoglycemia in diabetic patients with end-stage renal disease

21 January 2018

1 reference

12 December 2020

Epidemiology of severe hypoglycemia in the diabetes control and complications trial. The DCCT Research Group

1 reference

12 December 2020

Prolonged hypoglycemic crisis associated with glyburide

1 reference

12 December 2020

Glibenclamide-associated hypoglycaemia: a report on 57 cases

1 reference

12 December 2020

Hypoglycemia associated hospitalizations in a population with a high prevalence of non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Determination of glibenclamide and its two major metabolites in human serum and urine by column liquid chromatography

1 reference

12 December 2020

Drug-induced hypoglycemic coma in 102 diabetic patients

1 reference

12 December 2020

Glibenclamide induced prolonged hypoglycaemia

1 reference

12 December 2020

Glibenclamide is exceptional among hypoglycaemic sulphonylureas in accumulating progressively in β-cell-rich pancreatic islets

1 reference

12 December 2020

Prolonged hypoglycemia following acetohexamide administration. Report of two cases with impaired renal function

1 reference

12 December 2020

Hypoglycemia induced by oral hypoglycemic agents. Records of the French Regional Pharmacovigilance Centers 1985-1990

1 reference

12 December 2020

Drug-drug interactions in medical patients: effects of in-hospital treatment and relation to multiple drug use

1 reference

12 December 2020

Diabetes und Stoffwechsel

6

4

83

Bachmann

1995

1 reference

https://api.crossref.org/works/10.1007/S00228-003-0592-4

24 December 2023

Identifiers

1 reference

2 December 2017

1 reference